Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Randomized, Open-label 2-arm, parallel group study in approximately 20 healthy postmenopausal women to assess the safety of DARE-HRT1 Intravaginal Rings in two different dose strengths and the PK of progesterone and estradiol from the Intravaginal Rings.
Epistemonikos ID: 3932f862ef09954bbfdefe16cca66b038a8e9ab4
First added on: May 13, 2024